Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tesamorelin

Known as: GHRH(1-44), N-[(3E)-1-oxo-3-hexenyl]Somatoliberin (human pancreatic islet) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BackgroundAim of this review is to focus the attention on people living with HIV infection at risk of developing a cardiovascular… Expand
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
2014
2014
IMPORTANCE Among patients infected with human immunodeficiency virus (HIV), visceral adiposity is associated with metabolic… Expand
Is this relevant?
2012
2012
BACKGROUND Growth hormone–releasing hormone(GHRH), growth hormone, and insulin like growth factor 1 have potent effects on brain… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2012
2012
BACKGROUND Tesamorelin, a growth hormone-releasing hormone analogue, decreases visceral adipose tissue (VAT) by 15%-20% over 6-12… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2011
2011
OBJECTIVE To report the effects of tesamorelin, a growth hormone-releasing hormone analogue, on inflammatory and fibrinolytic… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
CONTEXT AND OBJECTIVE Strategies to augment pulsatile GH may be beneficial in patients with excess visceral adiposity, in whom GH… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
CONTEXT HIV patients treated with antiretroviral therapy (ART) often develop increased visceral adipose tissue (VAT). OBJECTIVE… Expand
Is this relevant?
2010
2010
BACKGROUND HIV-infected patients receiving antiretroviral therapy often demonstrate excess visceral fat. A growth hormone… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
OBJECTIVE Treatment of HIV patients with daily tesamorelin, a growth hormone-releasing factor analogue, for 26 weeks resulted in… Expand
  • figure 1
  • table 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Visceral adipose tissue accumulates during antiretroviral therapy in many patients who are infected with the human… Expand
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?